Stay updated with breaking news from Ischemic Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, BC / ACCESSWIRE / January 24, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), in follow-up to its press release dated September 16
AHA offers a standardized approach to rapidly evaluate patients with suspected transient ischemic attack in the emergency department, keeping in mind challenges faced by centers with limited resources.
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have announced a safety monitoring system that has flagged a concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent.
The Vaccine Safety Datalink (VSD), "a near real-time surveillance system," raised a safety concern about the Pfizer/BioNTech booster.
RUDN doctors analyzed the latest research on the use of RNA for the treatment and diagnosis of ischemic stroke.